Long-term rapamycin treatment suppresses IL-17-producing gamma delta T cells and blunts neuroinflammation in aging.
PloS one
View this publicationMember, Steering-Committee Member
Venusberg-Campus 1/99 53127 Bonn
My group is interested in elucidating pathways regulating immune cell function in ageing and neurodegenerative diseases, with a particular focus on myeloid cells, the components of the innate immune system.
In particular, we are interested in understanding the changes that characterize immune cells, such as microglia and neutrophils, with age and in Alzheimer’s disease, with the scope of identifying new pathways and molecular targets that can lead to therapeutic interventions.
PloS one
View this publicationSignal transduction and targeted therapy
View this publicationSTAR protocols
View this publication